TABLE 1.

Demographic and clinical data for domino liver transplant recipients who developed acquired amyloid neuropathy.

Demographic and Clinical Data (n = 12)
Gender (male), No. (%)	8 (66.6)
Personal history
- arterial hypertension No. (%)	11 (91.6)
- Dyslipidemia No. (%)	9 (75)
- Diabetes mellitus No. (%)	6 (50)
- Insulin-dependent diabetes. No. (%)	5 (41.6)
Initial transplant indication
- HCV LC, No. (%)	6 (50)
- HBV LC, No. (%)	2 (16.7)
- Alcoholic LC, No. (%)	1 (8.3)
- HBV and alcoholic LC, No. (%)	1 (8.3)
- HCV and alcoholic LC, No. (%)	1 (8.3)
- Autoimmune hepatitis LC, No. (%)	1 (8.3)
Age at the time of receiving DLT, mean (rang), years	57.7 (52, 65)
Age at onset of neurological symptoms, mean (rang), years	66.7 (57; 76)
Time between transplant and onset of symptoms, mean (rang), years	8.5 (5; 15)

DLT, domino liver transplant; HBV, hepatitis B virus; HCV, hepatitis C virus; LC, liver cirrhosis.